Home › Funds › Eukles Asset Management › LH
Eukles Asset Management position in LH
LABCORP HOLDINGS INC · Health Care
Eukles Asset Management reported holding 14,173 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 1.74% of its reported portfolio and ranking #17 among its reported holdings. Eukles Asset Management has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Eukles Asset Management's LH position evolved
Eukles Asset Management first disclosed a stake in LH in Q3 2023 at 17,379 shares (US$3.5M). The position peaked in Q3 2025 at 16,971 shares, worth US$4.9M. Across 13 filings, Eukles Asset Management increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 14,173 shares valued at US$4.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 17.38K | $3.49M | New |
| Q4 2023 | 17.40K | $3.96M | Hold |
| Q1 2024 | 18.00K | $3.93M | Add |
| Q2 2024 | 18.06K | $3.68M | Hold |
| Q3 2024 | 17.82K | $3.98M | Reduce |
| Q4 2024 | 16.88K | $3.87M | Reduce |
| Q1 2025 | 17.11K | $3.98M | Add |
| Q2 2025 | 17.02K | $4.47M | Hold |
| Q3 2025 | 16.97K | $4.87M | Hold |
| Q4 2025 | 16.86K | $4.23M | Reduce |
| Q1 2026 | 14.68K | $3.92M | Reduce |
| Q2 2026 | 14.24K | $3.99M | Reduce |
| Q3 2026 | 14.17K | $4.37M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LH and 13F data
LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LH
- VICTORY CAPITAL MANAGEMENT INC 3.92M sh · $1.21B · Q3 2026
- Boston Partners 2.95M sh · $908.74M · Q3 2026
- Allspring Global Investments Holdings, LLC 2.08M sh · $632.21M · Q3 2026
- Select Equity Group, L.P. 1.98M sh · $554.95M · Q2 2026
- THRIVENT FINANCIAL FOR LUTHERANS 705.96K sh · $217.51M · Q3 2026
- Navera Investment Management Ltd. 647.87K sh · $199.60M · Q3 2026
More on Eukles Asset Management
FAQ
How long has Eukles Asset Management held LH?
Eukles Asset Management has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Eukles Asset Management's current position in LH?
As of Q3 2026, Eukles Asset Management holds 14.17K shares of LH (LABCORP HOLDINGS INC), valued at $4.37M, representing 1.74% of its reported portfolio and ranking #17.
Has Eukles Asset Management been buying or selling LH?
In the latest 13F filing (Q3 2026), Eukles Asset Management held unchanged its position in LH. The position peaked in Q3 2025 at 16.97K shares.
Which other funds hold LH?
Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.